SCHEMBL3610459

SCHEMBL3610459

O=C(NC1CCNC1)c1[nH]c2cc(Cl)ccc2c1OC(=O)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.39
PTGS2 P35354 1/20 0.39
HDAC4 P56524 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HTR2A P28223 2/20 0.37
KCNH2 Q12809 2/20 0.37
DRD4 P21917 1/20 0.37
MAPK1 P28482 1/20 0.36
OPRK1 P41145 1/20 0.36
JAK2 O60674 1/20 0.36
SSTR1 P30872 1/20 0.35
SSTR4 P31391 1/20 0.35
CDK4 P11802 1/20 0.35
CDK2 P24941 1/20 0.35
CDK5 Q00535 1/20 0.35
PARP1 P09874 1/20 0.35
CHEK1 O14757 4/20 0.35
CDK2AP1 O14519 2/20 0.35
MC4R P32245 1/20 0.34
MC5R P33032 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3601876 0.89 HDAC4 (0.37) HTR6HDAC4HDAC6HTR2AKCNH2
SCHEMBL3612519 0.87 MAPK1 (0.37) HDAC4HDAC6HTR2AKCNH2DRD4
SCHEMBL3606656 0.86 PARP1 (0.41) HDAC4HDAC6MAPK1OPRK1PARP1
SCHEMBL3595472 0.86 MAPK1 (0.37) HDAC4HDAC6HTR2AKCNH2DRD4
SCHEMBL3612512 0.85 HTR6 (0.38) HTR6HDAC4HDAC6DRD4MAPK1
SCHEMBL3615739 0.83 MAPK1 (0.36) PTGS2HDAC4HDAC6DRD4MAPK1
SCHEMBL3612662 0.83 ADORA1 (0.45) PTGS2HDAC4MAPK1OPRK1JAK2
SCHEMBL3598969 0.81 EPHX1 (0.41) PTGS2HDAC4MAPK1OPRK1JAK2
SCHEMBL3595862 0.81 CDK2 (0.42) HTR6HDAC4DRD4SSTR1SSTR4
SCHEMBL3599370 0.78 CDK2 (0.41) HTR6HDAC4HDAC6HTR2AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035862-A1 NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035862-A1 NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF IDO2, IDO1, INMT HTR6 129/4885PTGS2 356/4885HDAC4 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.